CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label, Stratified, Single-arm Phase II Study of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumor (NET) After Failure of Cytotoxic Chemotherapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00363051
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:30.878211+00:00
Published At: 2012-03-30T00:00:00+00:00
Record Updated At: 2013-05-10
Results Posted At: 2012-03-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Islet Cell Carcinoma", "Neuroendocrine Carcinoma", "Neuroendocrine Tumor", "Pancreatic Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-05-10"
protocolSection.identificationModule.nctId: "NCT00363051"
protocolSection.identificationModule.officialTitle: "An Open Label, Stratified, Single-arm Phase II Study of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumor (NET) After Failure of Cytotoxic Chemotherapy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2012-03-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.